Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iodixanol versus iomeprol for prevention of contrast-induced nephropathy during percutaneous coronary intervention
2005-003832-24Phase 4Completed
- Sponsor
- Deutsches Herzzentrum München
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in coronary arteriosclerosis and chronic kidney disease (CKD) comparing Iodixanol 320 with Iomeprol 350 (2 arms). Started Apr 2006; status: completed.
02
Drugs
iodixanoliomeprol
03
Conditions
coronary arteriosclerosischronic kidney disease (CKD)
Beyond the preview
Go deeper on 2005-003832-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003832-24.